222 related articles for article (PubMed ID: 30444343)
1. Microneedle-Assisted Topical Delivery of Photodynamically Active Mesoporous Formulation for Combination Therapy of Deep-Seated Melanoma.
Tham HP; Xu K; Lim WQ; Chen H; Zheng M; Thng TGS; Venkatraman SS; Xu C; Zhao Y
ACS Nano; 2018 Dec; 12(12):11936-11948. PubMed ID: 30444343
[TBL] [Abstract][Full Text] [Related]
2. Improved antitumor activity of immunotherapy with BRAF and MEK inhibitors in BRAF(V600E) melanoma.
Hu-Lieskovan S; Mok S; Homet Moreno B; Tsoi J; Robert L; Goedert L; Pinheiro EM; Koya RC; Graeber TG; Comin-Anduix B; Ribas A
Sci Transl Med; 2015 Mar; 7(279):279ra41. PubMed ID: 25787767
[TBL] [Abstract][Full Text] [Related]
3. Copper Silicate Hollow Microspheres-Incorporated Scaffolds for Chemo-Photothermal Therapy of Melanoma and Tissue Healing.
Yu Q; Han Y; Wang X; Qin C; Zhai D; Yi Z; Chang J; Xiao Y; Wu C
ACS Nano; 2018 Mar; 12(3):2695-2707. PubMed ID: 29518321
[TBL] [Abstract][Full Text] [Related]
4. Improved overall survival in melanoma with combined dabrafenib and trametinib.
Robert C; Karaszewska B; Schachter J; Rutkowski P; Mackiewicz A; Stroiakovski D; Lichinitser M; Dummer R; Grange F; Mortier L; Chiarion-Sileni V; Drucis K; Krajsova I; Hauschild A; Lorigan P; Wolter P; Long GV; Flaherty K; Nathan P; Ribas A; Martin AM; Sun P; Crist W; Legos J; Rubin SD; Little SM; Schadendorf D
N Engl J Med; 2015 Jan; 372(1):30-9. PubMed ID: 25399551
[TBL] [Abstract][Full Text] [Related]
5. Clinical, Molecular, and Immune Analysis of Dabrafenib-Trametinib Combination Treatment for BRAF Inhibitor-Refractory Metastatic Melanoma: A Phase 2 Clinical Trial.
Chen G; McQuade JL; Panka DJ; Hudgens CW; Amin-Mansour A; Mu XJ; Bahl S; Jané-Valbuena J; Wani KM; Reuben A; Creasy CA; Jiang H; Cooper ZA; Roszik J; Bassett RL; Joon AY; Simpson LM; Mouton RD; Glitza IC; Patel SP; Hwu WJ; Amaria RN; Diab A; Hwu P; Lazar AJ; Wargo JA; Garraway LA; Tetzlaff MT; Sullivan RJ; Kim KB; Davies MA
JAMA Oncol; 2016 Aug; 2(8):1056-64. PubMed ID: 27124486
[TBL] [Abstract][Full Text] [Related]
6. Enhanced photodynamic efficacy towards melanoma cells by encapsulation of Pc4 in silica nanoparticles.
Zhao B; Yin JJ; Bilski PJ; Chignell CF; Roberts JE; He YY
Toxicol Appl Pharmacol; 2009 Dec; 241(2):163-72. PubMed ID: 19695274
[TBL] [Abstract][Full Text] [Related]
7. Biodegradable core-shell nanoassemblies for the delivery of docetaxel and Zn(II)-phthalocyanine inspired by combination therapy for cancer.
Conte C; Ungaro F; Maglio G; Tirino P; Siracusano G; Sciortino MT; Leone N; Palma G; Barbieri A; Arra C; Mazzaglia A; Quaglia F
J Control Release; 2013 Apr; 167(1):40-52. PubMed ID: 23298613
[TBL] [Abstract][Full Text] [Related]
8. Comparison of dabrafenib and trametinib combination therapy with vemurafenib monotherapy on health-related quality of life in patients with unresectable or metastatic cutaneous BRAF Val600-mutation-positive melanoma (COMBI-v): results of a phase 3, open-label, randomised trial.
Grob JJ; Amonkar MM; Karaszewska B; Schachter J; Dummer R; Mackiewicz A; Stroyakovskiy D; Drucis K; Grange F; Chiarion-Sileni V; Rutkowski P; Lichinitser M; Levchenko E; Wolter P; Hauschild A; Long GV; Nathan P; Ribas A; Flaherty K; Sun P; Legos JJ; McDowell DO; Mookerjee B; Schadendorf D; Robert C
Lancet Oncol; 2015 Oct; 16(13):1389-98. PubMed ID: 26433819
[TBL] [Abstract][Full Text] [Related]
9. Highly Emissive Dye-Sensitized Upconversion Nanostructure for Dual-Photosensitizer Photodynamic Therapy and Bioimaging.
Xu J; Yang P; Sun M; Bi H; Liu B; Yang D; Gai S; He F; Lin J
ACS Nano; 2017 Apr; 11(4):4133-4144. PubMed ID: 28320205
[TBL] [Abstract][Full Text] [Related]
10. Magnetic and pH dual-responsive mesoporous silica nanocomposites for effective and low-toxic photodynamic therapy.
Zhan J; Ma Z; Wang D; Li X; Li X; Le L; Kang A; Hu P; She L; Yang F
Int J Nanomedicine; 2017; 12():2733-2748. PubMed ID: 28442903
[TBL] [Abstract][Full Text] [Related]
11. Hair and nail adverse events during treatment with targeted therapies for metastatic melanoma.
Dika E; Patrizi A; Ribero S; Fanti PA; Starace M; Melotti B; Sperandi F; Piraccini BM
Eur J Dermatol; 2016 Jun; 26(3):232-9. PubMed ID: 27019511
[TBL] [Abstract][Full Text] [Related]
12. Discussion.
J Am Coll Surg; 2015 Apr; 220(4):593-5. PubMed ID: 25797744
[No Abstract] [Full Text] [Related]
13. Photo-responsive hollow silica nanoparticles for light-triggered genetic and photodynamic synergistic therapy.
Lin X; Wu M; Li M; Cai Z; Sun H; Tan X; Li J; Zeng Y; Liu X; Liu J
Acta Biomater; 2018 Aug; 76():178-192. PubMed ID: 30078423
[TBL] [Abstract][Full Text] [Related]
14. Dual-Drug-Loaded Topical Delivery of Photodynamically Active Lipid-Based Formulation for Combination Therapy of Cutaneous Melanoma.
Jain R; Paul M; Padaga SG; Dubey SK; Biswas S; Singhvi G
Mol Pharm; 2023 Jul; 20(7):3653-3671. PubMed ID: 37262335
[TBL] [Abstract][Full Text] [Related]
15. Combination of cyclodextrin complexation and iontophoresis as a promising strategy for the cutaneous delivery of aluminum-chloride phthalocyanine in photodynamic therapy.
Reis TA; Jaculi AE; Ramos KLV; Souza PEN; Veiga-Souza FH; Joanitti GA; Azevedo RB; Gratieri T; Cunha-Filho M; Gelfuso GM
Eur J Pharm Sci; 2019 Nov; 139():105056. PubMed ID: 31446076
[TBL] [Abstract][Full Text] [Related]
16. Verteporfin-loaded mesoporous silica nanoparticles inhibit mouse melanoma proliferation in vitro and in vivo.
Clemente N; Miletto I; Gianotti E; Invernizzi M; Marchese L; Dianzani U; Renò F
J Photochem Photobiol B; 2019 Aug; 197():111533. PubMed ID: 31254952
[TBL] [Abstract][Full Text] [Related]
17. Health-related quality of life impact in a randomised phase III study of the combination of dabrafenib and trametinib versus dabrafenib monotherapy in patients with BRAF V600 metastatic melanoma.
Schadendorf D; Amonkar MM; Stroyakovskiy D; Levchenko E; Gogas H; de Braud F; Grob JJ; Bondarenko I; Garbe C; Lebbe C; Larkin J; Chiarion-Sileni V; Millward M; Arance A; Mandalà M; Flaherty KT; Nathan P; Ribas A; Robert C; Casey M; DeMarini DJ; Irani JG; Aktan G; Long GV
Eur J Cancer; 2015 May; 51(7):833-40. PubMed ID: 25794603
[TBL] [Abstract][Full Text] [Related]
18. Co-delivery of IR-768 and daunorubicin using mPEG-b-PLGA micelles for synergistic enhancement of combination therapy of melanoma.
Tokarska K; Lamch Ł; Piechota B; Żukowski K; Chudy M; Wilk KA; Brzózka Z
J Photochem Photobiol B; 2020 Oct; 211():111981. PubMed ID: 32862088
[TBL] [Abstract][Full Text] [Related]
19. Dabrafenib plus Trametinib: a Review in Advanced Melanoma with a BRAF (V600) Mutation.
Dhillon S
Target Oncol; 2016 Jun; 11(3):417-28. PubMed ID: 27246822
[TBL] [Abstract][Full Text] [Related]
20. Phthalocyanine-Conjugated Upconversion NaYF
Kostiv U; Patsula V; Noculak A; Podhorodecki A; Větvička D; Poučková P; Sedláková Z; Horák D
ChemMedChem; 2017 Dec; 12(24):2066-2073. PubMed ID: 29105372
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
